Additionally, CEACAM6 was negatively correlated with EMT in pancreatic carcinomas [19] and CEACAM6 suppression could increase E-cadherin promoter activity in colorectal cancer [20]. Here, CEACAM6 is linked to exocrine pancreatic carcinoma.